GB Sciences Files Provisional Patent Application for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome (ARDS), the Leading Cause of Hospitalization and Deaths, Utilizing Its Cannabinoid Containing Complex Mixtures (CCCM(TM))

LAS VEGAS, NV / ACCESSWIRE / August 26, 2020 / GB Sciences, Inc. (OTCQB:GBLX) has filed a provisional patent application, assigned

Read more